How much does a box of generic dasatinib cost?
Dasatinib (Dasatinib) is an oral anti-leukemia drug that belongs to the tyrosine kinase inhibitor class of drugs and is commonly used to treat chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).
The domestic price of dasatinib (Startax) is about four to five thousand yuan per box, and it has been included in the medical insurance catalog. Patients can obtain a certain degree of reimbursement through the medical insurance policy.
In foreign countries, the price of generic drugs of dasatinib (Stardas) is relatively low, about a few hundred yuan per box. Although generic drugs are more affordable, patients need to consider factors such as quality and reliability when choosing one.
As a targeted therapy drug, the main mechanism of action of dasatinib is to block the growth and proliferation of leukemia cells by inhibiting the activity of tyrosine kinases. In patients with CML, dasatinib (Startase) is commonly used to treat Philadelphiachromosome-positive (Ph+) CML. This chromosomal abnormality results in the creation of a gene called the BCR-ABL fusion, which is one of the major causes of CML. Dasatinib can inhibit the activity of BCR-ABL kinase, thereby reducing the number of abnormal cells and slowing the progression of the disease.
In addition, dasatinib (Startase) is also used to treat some patients with acute lymphoblastic leukemia, especially those with Philadelphia chromosome-positive ALL.
Although dasatinib has achieved remarkable results in treating leukemia, it may also cause some side effects, such as nausea, vomiting, diarrhea, fatigue, etc. Serious side effects may include thrombocytopenia, abnormal liver function, arrhythmia, etc., so patients need to be closely monitored and communicate with their doctors while using dasatinib.
In general, dasatinib (Tasatinib), as a targeted therapy, has proven its effectiveness in CML and some ALL patients, and provided these patients with better survival and quality of life. However, patients need to pay close attention to side effects when using dasatinib and follow their doctor's recommendations for treatment.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)